96 patents in this list

Updated:

Automated insulin delivery systems face the challenge of maintaining precise glycemic control across varied patient conditions and behaviors. Current systems show mean absolute relative differences (MARD) of 9-14% in glucose sensing accuracy, while dealing with insulin absorption delays of 60-90 minutes and significant meal-related glucose excursions that can exceed 40 mg/dL within 15 minutes.

The core challenge lies in dynamically adjusting insulin delivery to maintain stable glucose levels while accounting for multiple variables including sensor accuracy, absorption variability, and unpredictable physiological responses.

This page brings together solutions from recent research—including orthogonally redundant glucose sensing systems, adaptive basal rate algorithms based on total daily insulin needs, machine learning approaches for meal detection, and closed-loop systems that operate without carbohydrate inputs. These and other approaches aim to improve glycemic control while reducing the burden of diabetes management.

1. Method for Predicting Meal and Exercise Events Using Glucose and Insulin Data with Residual Analysis

INSULET CORPORATION, 2024

Predicting meal and exercise events for a user with diabetes using their historical glucose and insulin data to improve insulin delivery. The method involves calculating residuals between actual and predicted glucose values over time. Positive residual rates indicate a meal event and negative rates indicate exercise. This allows the insulin pump to respond appropriately to meals and exercise without manual input.

2. Medication Dose Guidance System Utilizing Historical and Real-Time Physiological Data Analysis

ABBOTT DIABETES CARE INC., 2024

The systems, devices, and methods described herein for providing medication dose guidance, particularly insulin dose guidance, for diabetes management. The dose guidance is based on analyzing a user's historical and real-time physiological data, like glucose levels, diet, activity, etc., to determine optimal insulin doses. The guidance can also account for factors like hypoglycemic risk, glucose dysregulation, and low alarm frequency. The goal is to provide personalized and safe insulin dose recommendations without requiring users to manually analyze their data.

US2024225535A1-patent-drawing

3. Basal Insulin Infusion Rate Adjustment Method Using CGM-Derived Risk Metrics and Sensor Reliability-Dependent Control Algorithm

豪夫迈·罗氏有限公司, F HOFFMANN-LA ROCHE AG, 2024

Determining optimal basal insulin infusion rates for diabetes management using a CGM system that accounts for sensor reliability. The method involves calculating an adjustment to the basal rate based on a current risk metric indicating hypo/hyper risk and a control-to-range algorithm with an aggressiveness parameter. This allows customizing the basal rate response to the sensor data quality. If sensor reliability is low, the aggressiveness parameter reduces the basal rate adjustment to prevent over-correction. Conversely, if sensor reliability is high, the parameter allows more aggressive adjustments for better glucose control.

CN109564774B-patent-drawing

4. Method for Calculating Modification Coefficient to Adjust Adaptivity Rate in Automated Insulin Delivery Systems

INSULET CORP, 2024

Method to accelerate rate of adaptivity of automated insulin delivery (AID) systems for people with diabetes who experience significant variations in insulin needs. The method involves calculating a modification coefficient using a ratio of current insulin variability to historical variability. This coefficient is used to generate a faster adaptive rate for calculating daily insulin requirements. This allows the AID system to more quickly respond to user's changing insulin needs, reducing time in hyper/hypoglycemia when they experience sudden spikes or drops in sensitivity.

5. Method for Insulin Dosing Adjustment Using Historical Glucose Data and Insulin Sensitivity Calculation

诺和诺德股份有限公司, NOVO NORDISK AS, 2024

Robust method for optimizing insulin dosing to achieve target glucose levels in diabetes patients. It involves using historical autonomous glucose measurements and insulin infusions to calculate glycemic risk and insulin sensitivity factors for a patient. These factors are then used to generate a personalized basal rate titration plan and fasting glucose profile model. The plan guides insulin adjustments during future time periods to minimize risks and maintain target fasting glucose.

6. Insulin Dose Supervision System with Machine Learning-Based Personalized Adjustment Model

SHANGHAI MINHANG HOSPITAL OF INTEGRATED TRADITIONAL CHINESE AND WESTERN MEDICINE, SHANGHAI MINHANG HOSPITAL OF INTEGRATED TRADITIONAL CHINESE AND WESTERN MEDICINE SHANGHAI MINHANG DI, 2024

Self-learning insulin dose supervision system for diabetes patients that uses machine learning to calculate personalized insulin doses based on a patient's blood sugar levels and meal parameters. The system acquires patient data, learns the relationship between blood sugar, carbs, insulin, and post-meal levels, and generates a dynamic medication adjustment model for that patient. It then calculates the pre-meal insulin dose using the model and alerts the patient if the calculated dose exceeds the doctor's limits or changes too much. This allows personalized insulin adjustment and monitoring beyond what a doctor can provide.

7. Integrated System for Data Transfer and Display Between Insulin Pens and Monitoring Platform

ABBOTT DIABETES CARE INC., 2024

Integrated diabetes management system that connects insulin pens with a common viewing platform to enable transfer of data between the devices. The system allows users to view insulin doses, glucose levels, and other metrics together. It provides feedback on the pen display when doses deviate from recommendations. The pens also lock if set to higher than recommended doses. The system aims to improve adherence and safety by integrating insulin delivery with glucose monitoring and providing dose recommendations and feedback.

8. System for Automated Risk Assessment of Glycemic Events Using Insulin Pump Data and Machine Learning

INSULET CORPORATION, 2024

Automatically determining the user's risk of hypoglycemia or hyperglycemia based on factors calculated using data available in an insulin pump or diabetes management system. The system analyzes factors like current glucose, insulin delivery history, and other datasets to calculate a risk. It provides real-time alerts to the user when the risk is indicated, along with recommendations for mitigating the risk. The risk calculation can also be adjusted based on factors like exercise to account for how activities affect glucose levels. Machine learning can further improve the risk calculation by weighting factors based on accuracy.

9. Glucose Control System with Adaptive Insulin Dosing Based on Long-Acting Insulin Administration

Beta Bionics, Inc., 2023

A glucose level control system for diabetes management that can adapt insulin dosing based on long-acting insulin administration. The system determines a long-acting insulin dose recommendation based on fast-acting insulin during a first therapy period. During a second therapy period after long-acting insulin administration, it modifies fast-acting insulin dosing based on the recommendation. This enables optimization of overall insulin therapy when both fast-acting and long-acting insulins are used.

10. Pen-Based Insulin Delivery System with Adaptive Gaussian Process Model for Insulin Sensitivity Estimation

北京理工大学, BEIJING INSTITUTE OF TECHNOLOGY, 2023

A system and method for intelligent insulin dosing using a pen-based insulin delivery device. The system estimates insulin sensitivity adaptively to improve accuracy of insulin dose recommendations. It uses a Gaussian process model trained on patient data to predict blood sugar levels considering insulin sensitivity. A classifier based on physiological scenes like exercise, emotion, and ketosis relief further refines the prediction. This adaptive insulin sensitivity estimation significantly improves blood sugar prediction for better dosing decisions.

11. System for Centralized Integration of Glucose Monitoring and Insulin Delivery Devices with Automated Data Synchronization

ABBOTT DIABETES CARE INC, 2023

Integrated diabetes management system that connects glucose monitoring devices, insulin pens, and other devices to a central reader and displays a unified view of glucose levels, insulin doses, and other data. The system aims to provide better diabetes management by allowing users to view and analyze glucose and insulin data in a more actionable and correlated way. It also enables automated data transfer from devices like insulin pens to the central reader. The system can display metrics like average glucose, low glucose events, insulin amounts, and carbohydrate intake over time. It can also provide alerts for missed doses or high glucose levels. The centralized view and analytics aim to provide more insights and enable better diabetes management compared to viewing device-specific logs separately.

12. Glucose Prediction Model Customization in Insulin Delivery Devices Using User-Specific Regression-Based Weightings

INSULET CORPORATION, 2023

Customizing a glucose prediction model in an insulin delivery device to accurately predict glucose levels for users with insulin sensitivity or insulin insensitivity. The customization is done based on the user's past glucose readings using regression analysis to determine weightings for those readings. These weightings are then used to predict future glucose levels for the user. This customized prediction model provides more accurate glucose predictions for users with varying insulin sensitivity, improving insulin dosing decisions.

US2023372613A1-patent-drawing

13. Basal Insulin Titration System Utilizing Historical Data and Hypoglycemia Event Analysis for Automated Dose Adjustment

DEXCOM INC, 2023

Basal insulin titration adjustment for patients with Type 2 Diabetes that can reduce burden on health care providers through automated, patient-facing deployments. The adjustment includes reading in historical data including CGM History, Dosed Insulin History, Reported Hypoglycemia (Hypo) History, and a Recommendation History, generating a adjusted insulin dose using the historical EGVs, the Hypoglycemic report history specifying a time and severity of credible hypoglycemic events reported by the subject, and producing the adjusted basal insulin dose using the hypoglycemic report history as an additional input.

14. Continuous Glucose Monitoring-Based Automated Basal Insulin Dose Adjustment System with Historical Data Integration and Personalized Dose-Response Modeling

Dexcom, Inc., 2023

CGM-based automated basal insulin titration for Type 2 Diabetes patients uses historical CGM data, basal insulin doses, hypoglycemia reports, and past recommendations to generate adjusted insulin doses that minimize hypoglycemia risk and avoid overdosing. The method involves estimating personalized dose-response models from CGM metrics, regularizing fits in the early days, incorporating glucose variability, and ensuring safe dose changes. By leveraging CGM's comprehensive view of glucose levels, this approach aims to improve insulin titration compared to fingerstick-based manual titration, reducing the risk of overdosing and minimizing hypoglycemia.

US20230338654A1-patent-drawing

15. Insulin Dosing Adjustment Method Using Gradient Analysis of Historical Glucose Data

诺和诺德股份有限公司, NOVO NORDISK AS, 2023

Optimizing insulin dosing for diabetes management by dynamically adjusting the ratio of basal vs mealtime insulin without changing the total daily dose. The method involves analyzing historical glucose data to identify fasting events and calculate gradients. If gradients indicate basal deficiency, recommend increasing mealtime insulin. If gradients indicate mealtime deficiency, recommend increasing basal insulin. This allows fine-tuning of insulin regimens without trial-and-error adjustments.

CN109564776B-patent-drawing

16. Automated Insulin Dosing System with Centralized Glucose Trend Analysis for Subcutaneous Pumps

Aseko, Inc., 2023

An automated insulin dosing system for diabetes patients using subcutaneous insulin pumps operates via a central server that receives blood glucose data from glucose meters. The server calculates optimal insulin dosages based on aggregated glucose trends and transmits them to the patient's insulin pump. This system enables personalized insulin dosing based on historical glucose patterns rather than relying solely on current measurements.

US20230293012A1-patent-drawing

17. System for Personalized Insulin and Carbohydrate Administration Using Machine Learning and Continuous Glucose Monitoring Data

Minerva Analysis LLC, 2023

Managing diabetes using personalized machine learning algorithms and patient data to recommend and automatically administer insulin and carbohydrates. The system collects continuous glucose monitor (CGM) data, processes it, and uses machine learning to predict optimal treatments. It provides real-time updates to patients and caregivers and allows remote intervention. The algorithms are personalized based on factors like activities, foods, and weight. The system also facilitates communication between patients, caregivers, and providers.

US2023298754A1-patent-drawing

18. Apparatus for Analyzing Blood Glucose Data and Adjusting Insulin Dosages Using Algorithmic Evaluation

HYGIEIA, INC., 2023

Apparatus to optimize insulin dosage regimen for diabetes patients between clinic visits. The device analyzes patient blood glucose data and adjusts insulin dosages to maintain future levels within a range. It uses algorithms to determine how much to vary long-acting, meal, and correction insulin based on past glucose trends. The device stores the initial insulin regimen set by the doctor, and then continually evaluates if adjustments are needed based on new glucose readings. It can also suggest immediate insulin corrections for high glucose readings.

19. Insulin Pump Interface with User-Adjustable Subjective Parameter Input for Algorithmic Coefficient Modification

INSULET CORPORATION, 2023

Allowing users of insulin pumps to customize insulin delivery parameters in a way that is easier and more intuitive compared to traditional methods. It presents a user interface with input devices for subjective parameters like "insulin need" that are interpreted by the pump's automatic insulin delivery algorithm. When the user inputs a subjective insulin need, it modifies a coefficient value used in the algorithm's calculations. This allows users to adjust a key parameter without having to understand the complex factors used by the algorithm. The pump then collects physiological data and determines insulin dosage based on the modified coefficient value and the collected data. This provides personalized insulin delivery that adapts to the user's specific needs and conditions.

20. Decision-Making System for Insulin Dosing Using Expert Rule-Based Analysis

东北大学, NORTHEASTERN UNIVERSITY, 2023

A decision-making method for precise insulin dosing in diabetes treatment based on expert rules. The method involves using a decision-making system to accurately determine insulin dosage based on a set of expert rules. The system analyzes factors like meal size, timing, blood sugar levels, and insulin history to make insulin dosing recommendations. This aims to improve diabetes management by providing personalized insulin administration guidance using expert knowledge.

21. Self-Adaptive Insulin Infusion System with Derivative-Based Estimation and Dual-Rate Bolus Delivery

22. Automated Blood Glucose Control System with Adaptive Parameter Predictive Algorithm for Insulin Delivery

23. Automated Insulin Delivery System with Probabilistic Glycemic Disturbance Profiling and Anticipatory Dosage Adjustment

24. Deep Learning Model Utilizing CNN and LSTM for Temporal Prediction of Blood Glucose Levels in Type 1 Diabetes

25. Closed-Loop Insulin Pump with Pre-Meal Insulin Adjustment Mode

Request the full report with complete details of these

+76 patents for offline reading.

By utilizing cutting-edge technologies and doing data analysis, scientists are creating insulin therapy systems that are customized to each patient's unique glucose patterns. By simplifying blood sugar management and lowering the risk of hypo- and hyperglycemia, these developing solutions have the potential to significantly improve the quality of life for diabetics.